Demographic Analysis

Goals

To get hard stats and data related to cancer and prostate cancer incidence and prevalence in Italy.

Early Findings

Our first round of research unveiled the following information:
  • The total number of new prostate cancer cases reported in Italy in 2018 amounted to 43,837. The figure represents 10.7% of the total number of newly reported cancer cases (2018).
  • Nearly 409,808 cancer cases were reported in Italy in the year 2018.
  • Based on geographical stats, Lombardy (Italy) was reported to have the highest number (30,000 cases) of newly reported cases of cancer. Lazio and Emilia-Romagna were the second and third on the list with the most number of recently reported cancer cases, and Aosta Valley had the least number of cancer cases for the year 2019, which amounted to only 300 cases in total.
  • " In 2019, 37,000 males were estimated to be newly diagnosed with prostate cancer in Italy. Pertaining to new diagnosis among males, prostate cancer was the one with the highest incidence."
  • "Breast cancer was the most common one among females. In 2019, breast cancer accounted for 30 percent of new cancer cases diagnosed among women; colorectal and lung cancer followed with shares of 12 percent each."
  • "The number of new cancer cases among females in Italy forecasted for 2019 was very consistent and varied greatly according to the type of cancer considered; according to data, breast cancer was the most prevalent cancer type among females, with 53,000 estimated new cases. Colorectum and lung cancer followed with 22,000 and 13,000 forecasted cases respectively."

Proposed next steps:

You need to be the project owner to select a next step.
Our background research was able to provide the requested information for Italy, as requested. Information about age demographics was not found in the public domain. We propose further research to provide information about the remaining regions: EU and Australasia. For each region, we will focus on the following criteria: 1) the number of people living with diabetes, cancer, and heart disease and 2) the demographic distribution (age, gender) and private/public expenditure per person being treated for each disease.
We also propose further research to provide details of the private/public expenditure per person being treated for cancer (in general), prostrate cancer, and breast cancer in Italy.